Savara (SVRA) EBT Margin (2013 - 2020)

Savara (SVRA) reported EBT Margin of 1354200.0% for Q4 2020, down 30732.02% quarter-over-quarter from 4392.19% in Q3 2020.

Savara (SVRA) EBT Margin (2013 - 2020) Analysis & Trends

Savara (SVRA) has 5 years of EBT Margin data on file, last reported at 1354200.0% in Q4 2020.

  • EBT Margin for Q4 2020 came in at 1354200.0%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was 4136800.0% (changed N/A YoY), and the FY2020 annual result was 19759.53%, changed N/A from the prior year.
  • EBT Margin declined to 1354200.0% in Q4 2020 per SVRA's latest filing, from 4392.19% in the prior quarter.
  • Over five years, EBT Margin peaked at 12738.3% in Q2 2017 and troughed at 1354200.0% in Q4 2020.
  • A 3-year average of 226544.77% and a median of 4967.9% in 2017 frame the typical range for EBT Margin.
  • On a YoY basis, EBT Margin climbed as much as 2182037 bps in 2016 and fell as far as 2182037 bps in 2016.
  • A 3-year view of EBT Margin shows it stood at 700.0% in 2016, then jumped by 1920 bps to 12738.3% in 2017, then plunged by 10731 bps to 1354200.0% in 2020.
  • Business Quant data shows SVRA's EBT Margin at 1354200.0% in Q4 2020, 4392.19% in Q3 2020, and 12738.3% in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Savara 1.39 Bn 1.39 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 -1,354,200.00%
Sep 30, 2020 -4,392.19%
Jun 30, 2017 12,738.30%
Mar 31, 2017 -5,543.62%
Dec 31, 2016 -700.00%
Sep 30, 2016 -7,171.11%
Dec 31, 2015 -22,520.37%
Jun 30, 2013 -971.00%
Mar 31, 2013 -1,402.16%